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this study compared Zr-Mo alloys with commercial metallic biomaterials. it was observed that the 
Zr-Mo alloys exhibited favourable mechanical properties, particularly the Zr-10Mo alloy, which 
showed the highest strength to Young’s modulus ratio among all evaluated metals. these alloys also 
exhibited the lowest magnetic susceptibilities, which are important for magnetic resonance imaging 
(MRi). However, both Zr- and ti-based metals yielded comparable artifacts. it was concluded that the 
magnetic susceptibility must differ considerably to afford significantly improved MRI quality owing 
to the increased importance of non-susceptibility-related artifacts when comparing materials with 
relatively similar magnetic susceptibilities.
Metals are still competitive with other classes of materials in the application and development of medical implants 
in various fields of medicine, such as orthopaedics, neurology, cardiology, and dentistry. Owing to their combined 
properties, including strength and toughness, and the possibility of employing cost-effective manufacturing pro-
cesses, metals are typically the best biomaterial choice when compared to ceramics and polymers, as well as com-
posites. The use of metallic devices in the human body is usually required for the replacement and stabilization 
of damaged bone tissues in orthopaedic practice. The classical examples of such applications include temporary 
plates and screws, and permanent total hip replacements. Other applications include usage in vascular stents, 
aneurysm clips, pacemakers, dental implants, wire sutures, etc.1–3.
Despite being similar to Ti alloys, particularly in their physical metallurgy and other properties4, Zr-based 
alloys have received comparatively little attention as biomaterials. Zr and its alloys exhibit excellent biocompat-
ibility, good corrosion behaviour, and favourable mechanical properties5–11. Specifically, these alloys are suitable 
for applications in orthopaedic and dentistry owing to their low Young’s modulus. A major issue associated with 
using metallic materials in long-term implants is the mismatch between the bone and the employed device. Rigid 
implants can promote the stress shielding effect and cause bone resorption, strongly affecting the medium- to 
long-term quality of the surgical intervention12. Accordingly, alloys with a low Young’s modulus have been tar-
geted for this type of application13,14. In this regard, Zr alloys are similar to Ti alloys. For instance, Guo et al.10 
reported a Young’s modulus of only 44 GPa for a β-type Zr-12Nb-4Sn alloy, which is relatively close to that of 
human cortical bone (around 20 GPa15) and is similar to as the best results reported for Ti alloys16. More recently, 
increasing interest in Zr and its alloys has been justified by their reduced magnetic susceptibility, which has been 
claimed to reduce the magnetic resonance imaging (MRI) artifacts7,10,11,17,18.
MRI is a powerful non-invasive tool for medical diagnosis that relies on the nuclear magnetic resonance 
phenomenon. It presents a high spatial resolution and usually outperforms X-ray computed tomography (CT) in 
contrasting soft tissues; moreover, MRI does not involve an ionizing radiation. Owing to these advantages, MRI 
is considered as one of the most important techniques for imaging the human anatomy19. Nonetheless, it is well 
known that metallic materials can affect the quality of MR images by introducing artifacts due to perturbation 
of the magnetic field uniformity19–23. The artifacts are dependent on the size, shape, orientation in relation to 
the magnetic field, and composition of the metallic device23. Considering the importance of MRI for medical 
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diagnosis and procedures, as well as the fact that patients with metallic implants have to eventually submit them-
selves to MRI, it is very important to select and apply materials with good MRI compatibility, which includes 
properties such as low magnetic susceptibility values24. Upon analysis of a few alloys and pure metals, Imai 
et al.25 found good linear relationships between the observed artifact volume and the magnetic susceptibility 
values. Based on such correlations, the authors concluded that low magnetic susceptibility alloys with enhanced 
MRI compatibility can be developed.
In the present investigation, we focused on the capability of Zr-based alloys in decreasing the MRI artifacts in 
comparison to well-known metallic biomaterials. Commercially pure (cp) Zr and two binary alloys, Zr-1Mo and 
Zr-10Mo, were compared to commercially available biomedical alloys: 18Cr-14Ni-2.5Mo stainless steel (ASTM 
F138), Co-18Cr-6Mo (ASTM F1537), Ti-6Al-4V (ASTM F136), and cp Ti-Gr2 (ASTM F67) (all compositions 
are in wt.%). Furthermore, the fundamental microstructural and mechanical properties of the Zr-based materials 
were also studied.
Results and Discussion
Figure 1a–c exhibit the microstructures of the furnace-cooled cp Zr, Zr-1Mo, and Zr-10Mo samples. As the 
Mo content increased, the volume fraction of the β phase (BCC crystal structure) also increased; this result was 
expected by the addition of a β-stabilizing element. When 1 wt.% of Mo was added to cp Zr, α phase (HCP crystal 
structure) colonies became more refined, forming the typical basket-weave structure (Fig. 1b). The presence of 
a small amount of β phase in this alloy is indicated by the indexed β (200) peak in the XRD pattern of Fig. 1d. 
Contrarily, the β phase is the major constituent in the Zr-10Mo alloy. As can be seen in Fig. 1c, etched zones at the 
β-grain boundaries and inside these same grains are mainly related to pits introduced during chemical polishing 
(conventional and electrochemical polishing were both tried, but neither provided significantly better results), 
but they can also correspond to small α-phase precipitates. However, even if the α-phase precipitates are present, 
their volumetric fraction is small, since no peak associated with this specific phase can be observed in the XRD 
pattern (Fig. 1d).
The representative mechanical performance in the compression regime of the Zr-based materials under evalu-
ation can be observed in Fig. 2a. Both strength and ductility increased with Mo content. While fracture occurred 
approximately at the same strain for Zr and Zr-1Mo, no fracture was observed in the Zr-10Mo alloy; this can 
be attributed to the high β volumetric fraction in Zr-10Mo, which is typically ductile in the absence of the ω 
phase. The values obtained for the 0.2% compression yield strength were 566 ± 4, 718 ± 19, and 997 ± 41 MPa 
for cp Zr, Zr-1Mo, and Zr-10Mo, respectively. The higher strength of Zr-1Mo in comparison to cp Zr is related 
to both microstructure refinement and solid solution effects, whereas solid solution effects are believed to be 
the main strengthening mechanism for alloys with increasing Mo content (Zr-1Mo to Zr-10Mo) because the 
total boundary area decreases when the Mo content is increased. The minor α-phase (if present) precipitation in 
the Zr-10Mo alloy did not play any significant role in its mechanical behaviour. This alloy exhibited a compres-
sion yield strength of 1057 ± 20 MPa and the same ductility as a sample with a full β microstructure, which was 
obtained after rapid cooling from the β field (water quenching after the solution heat treatment). Interestingly, 
Zr-10Mo alloy also presented the lowest Young’s modulus (76 ± 1 GPa), while the cp Zr and Zr-1Mo alloys exhib-
ited elastic properties that were significantly higher and similar to each other (the Young’s moduli were 97 ± 1 
and 98 ± 1 GPa, respectively). These values are consistent with those reported in the literature9,26. Essentially, the 
α phase presents a modulus of approximately 100 GPa, whereas the values observed for the β phase tend to be 
Figure 1. Visible-light microscopy images of the microstructure for the furnace-cooled (a) cp Zr, (b) Zr-1Mo, 
and (c) Zr-10Mo samples and (d) their respective XRD patterns.
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lower. For instance, Zhou et al.9 obtained Young’s modulus values of 99.5, 98.8, and 73.2 GPa for cp Zr, Zr-1Mo, 
and Zr-10Mo, respectively. Although they were evaluated in the solution-treated condition, analogous phases 
were found; in this case, the hexagonal martensite α’ was confirmed instead of the original α phase in Zr-1Mo, 
and a full β microstructure was obtained for Zr-10Mo. In comparison with commercial metals that are typically 
applied as biomaterials in the human body (Fig. 2b), Zr and its alloys appear to exhibit a good balance between 
strength and ductility, at least under the conditions examined in this study. Accordingly, from the mechanical 
properties standpoint, it is reasonable to conclude that Zr-based metals can compete with the current materials. 
The Zr-10Mo alloy is particularly important owing to its lower Young’s modulus compared to cp Ti-Gr2, which 
has the lowest value among the commercial metals evaluated (between 103–107 GPa27). Furthermore, because of 
its enhanced mechanical performance, Zr-10Mo also possesses the highest ratio of compression yield strength 
to Young’s modulus [~13.1 × 10−3 against ~8.9 × 10−3 for the Ti-6Al-4V alloy (second largest ratio)], which is 
extremely beneficial for use in high strength medical implants with relatively low levels of rigidity.
The magnetic susceptibilities of the furnace-cooled cp Zr, Zr-1Mo, Zr-10Mo together with the other metal-
lic biomaterials are shown in Fig. 3. Notably, the Zr-based materials exhibited the lowest values, varying from 
1.36 10−6 cm3 g−1 for cp Zr to 1.05 10−6 cm3 g−1 for Zr-1Mo, and finally to 1.29 10−6 cm3 g−1 for Zr-10Mo. The 
observed trend is in good agreement with the results published by Suyalatu et al.28. As the α phase is dominant 
in cp Zr and Zr-1Mo alloy, their dissimilar susceptibilities can be explained on the basis of their chemical com-
position, as the magnetic susceptibility of Mo is lower than that of Zr (0.75 and 1.32 10−6 cm3 g−1, respectively29). 
However, a simple and direct relationship based on the Mo content could not be established. Moreover, a further 
increase in the Mo content did not cause the magnetic susceptibility to diminish, but instead to increase. This 
Figure 2. Representative stress-strain curves obtained in the compression tests for the (a) furnace-cooled cp Zr, 
Zr-1Mo, and Zr-10Mo samples, and (b) commercial 18Cr-14Ni-2.5Mo stainless steel (ASTM F138), Co-18Cr-
6Mo (ASTM F1537), Ti-6Al-4V (ASTM F136), and cp Ti-Gr2 (ASTM F67) samples.
Figure 3. Mass magnetic susceptibility of the furnace-cooled cp Zr, Zr-1Mo, and Zr-10Mo samples in 
comparison to commercial 18Cr-14Ni-2.5Mo stainless steel (ASTM F138), Co-18Cr-6Mo (ASTM F1537), Ti-
6Al-4V (ASTM F136), and cp Ti-Gr2 (ASTM F67) samples.
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can be mainly attributed to the β phase, which has been reported to possess the highest magnetic susceptibility 
among those typically found in Zr alloys7,28,30. Figure 3 also shows that while the Zr-based materials have the low-
est magnetic susceptibilities, the Ti-based materials are the second lowest magnetic susceptibilities. Nonetheless, 
Ti-6Al-4V and cp Ti-Gr2 still exhibit values almost three or two times larger than the Zr-based materials, con-
sistent with previous investigations7,10,11,17,28,30. Based on these promising results, it is usually claimed that the 
reduced magnetic susceptibilities of Zr-based materials could sharply reduce the occurrence of MRI artifacts. 
However, they have never been tested and compared with other metallic materials in real clinical MRI practice.
Figure 4 shows the MRI performance of all the metals evaluated during this study. Surprisingly, we did not 
observe the expected magnetic susceptibility dependence when comparing artifacts of Zr- and Ti-based mate-
rials. For instance, Fig. 4a,b depict the 2D artifact appearance of the metallic samples for both spin echo (SE) 
and gradient echo (GRE) pulse sequences, respectively. It is noteworthy that excluding the 18Cr-14Ni-2.5Mo 
stainless steel and Co-18Cr-6Mo alloy, no clear difference can be observed. The same can be pointed out for the 
3D artifacts depicted in Fig. 4c,d for the SE and GRE pulse sequences, respectively. Although some morpholog-
ical differences can be verified among the artifacts of Zr- and Ti-based materials, their volumes seem to be very 
similar. A more detailed analysis is provided in Fig. 5a,b, which present the measured artifact areas and volumes, 
respectively. At first glance, the trend marked in these graphics resembles the previous trend for magnetic sus-
ceptibility (Fig. 3). However, a more careful look shows that no obvious trend exists between the results generated 
by the Zr- and Ti-based metals. For the SE sequence, the measured areas were 96.0, 85.3, 92.6, 414.3, 260.3, 90.4, 
and 95.3 mm2 for cp Zr, Zr-1Mo, Zr-10Mo, 18Cr-14Ni-2.5Mo stainless steel, Co-18Cr-6Mo, Ti-6Al-4V, and cp 
Ti-Gr2 materials, respectively. Consistent with results published in literature21,25, the areas observed for the GRE 
sequence were much larger: 291.3, 274.8, 248.1, 967.9, 591.1, 320.4, and 286.0 mm2 for Zr, Zr-1Mo, Zr-10Mo, 
18Cr-14Ni-2.5Mo stainless steel, Co-18Cr-6Mo, Ti-6Al-4V, and cp Ti-Gr2, respectively. If these areas are plotted 
against the measured magnetic susceptibilities, an overall good linear relationship can be obtained (Fig. 5c), as 
reported by Imai et al.25. Nonetheless, there is a clear variability of the Zr and Ti points in relation to the fitted 
curves, showing that the studied Zr-based materials could not provide effectively lower artifact levels in com-
parison to the studied Ti-based materials despite their lower magnetic susceptibilities. For instance, if the lowest 
artifact areas for Zr- and Ti-based samples are compared, the reduction in the artifact area is only 5.6% for a 
reduction of  69.9% in the magnetic susceptibility using the SE sequence, and it is 13.3% for a reduction of 46.7% 
in the magnetic susceptibility using the GRE sequence. In the case of the 18Cr-14Ni-2.5Mo stainless steel and 
Co-18Cr-6Mo alloys, the artifact differences compared to Zr- and Ti-based metals are very prominent because of 
their much larger magnetic susceptibilities. As expected, the correlation between the calculated volumes and the 
measured magnetic susceptibilities (Fig. 5d) is consonant with the previous result (Fig. 5c), leading to a similar 
analysis. Based on these observations, it is possible to conclude that the magnetic susceptibility should vary signif-
icantly to provide relevant improvements in MRI. Therefore, it is believed that when the magnetic susceptibilities 
are relatively close, non-susceptibility-related artifacts, which are dependent, for example, on the size and orienta-
tion of the sample31, can significantly affect the overall MRI quality and cause deviations from the normally linear 
relationship between the magnetic susceptibility and the artifact area or volume. More studies are now required 
because this investigation was limited to samples with only one size and shape, as well as their orientation with 
Figure 4. MRI of the Zr-based and other commercial metallic biomaterials: (a,b) 2D artifacts observed 
for SE and GRE pulse sequences, respectively; (c,d) 3D artifacts observed for SE and GRE pulse sequences, 
respectively; and (e) typical analysed sample. For interactive visualization click on the 3D PDF models in the 
Supplementary Material.
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respect to the main magnetic field was kept constant. Hence, it is important to verify whether similar conclusions 
would also be drawn by using different geometric features and under other experimental conditions.
In summary, this investigation showed that cp Zr, Zr-1Mo, and Zr-10Mo are favourable materials for biomedi-
cal and dentistry applications. Based on their mechanical properties, they can compete with typical metals in cur-
rent usage; the Zr-10Mo alloy is particularly promising because of its relatively low Young’s modulus (~75 GPa). 
These alloys also presented low magnetic susceptibilities, which is an important property for MRI. In comparison 
with the cp Ti-Gr2, the Zr-based materials exhibited approximately half of its measured magnetic susceptibil-
ity. However, this did not translate effectively into smaller artifacts during MRI. Both Zr- and Ti-based metals 
produced similar artifacts without any obvious correlation between the measured artifact area or volume and 
the magnetic susceptibility. It was concluded that the magnetic susceptibility must vary significantly to obtain a 
noticeable enhancement, since non-susceptibility-related artifacts can significantly affect the overall MRI quality 
when comparing materials with relatively close magnetic susceptibilities.
Methods
Mo was chosen as a viable alloying element because it is a strong β-stabilizer, has low cytotoxicity32, and low 
magnetic susceptibility11,25. The Zr and its alloys were arc-melted in an inert atmosphere using nuclear grade 
Zr (>99%, residual levels of Hf <5000 ppm and Fe <1000 ppm) and pure Mo (99.95%). The as-cast ingots 
were homogenized at 1000 °C for 12 h and then hot-rolled at 800 °C until a height reduction of approximately 
60% was achieved. Thereafter, a solution heat treatment was applied at 1000 °C for 1 h, followed by furnace 
cooling. This processing route enabled favourable relationship between the mechanical properties (this will 
be discussed in a subsequent publication). The microstructures produced in the samples were characterized 
using visible-light microscopy and X-ray diffraction (XRD). Chemically polished samples (Kroll solution) were 
observed by a Leica DM IL LED microscope, while XRD was carried out via a PANalytical X’Pert PRO instrument 
equipped with CuKα radiation. The Young’s moduli were determined by ultrasonic measurements employing a 
Panametrics-NDT 5072PR pulser-receiver and piezoelectric transducers operating at 5 MHz13,14. For the follow-
ing experiments, the Zr-based samples as well as commercial 18Cr-14Ni-2.5Mo stainless steel, Co-18Cr-6Mo, 
Ti-6Al-4V, and cp Ti-Gr2 samples were evaluated. Mechanical compression tests were performed at 2 mm min−1 
at room temperature in an MTS 810 universal testing machine using three specimens of each alloy, 2 mm in diam-
eter and 4 mm long. The magnetic susceptibility values were determined at room temperature using a Quantum 
Design PPMS system and applying a magnetic field of 0.35 T. Finally, MRI was performed at a static field strength 
Figure 5. MRI of the Zr-based and other commercial metallic biomaterials: (a,b) measured artifact areas and 
volumes, respectively; (c,d) magnetic susceptibility versus artifact area and volume correlations, respectively.
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of 1.5 T in a Toshiba Vantage machine using a standard head coil. Cylindrical specimens with a diameter of 2 mm 
and a length of 8 mm were embedded in commercial gelatine and thereafter positioned in the MRI scanner with 
their longitudinal axis aligned with the main magnetic field direction (z direction). Several slices were taken to 
cover the entire artifact extension using spin echo (SE) and gradient echo (GRE) pulse sequences. For the SE 
images, the parameters included a repetition time (TR) of 500 ms, echo time (TE) of 20 ms, and flip angle of 90°; 
for the GRE images, a TR of 500 ms, TE of 15 ms, and flip angle of 30° were employed. The slice with the largest 
artifact for each material and in each condition was selected and analysed with ImageJ software33 to determine 
the artifact area observed in the sagittal plane. The artifact area was estimated by pixels that deviated from the 
mean window level by more than ±30% of the free-artifact region of the image (background), similar to the pro-
cedure described in detail by Kawabata et al.31. Lastly, the artifact volume was estimated using a medical imaging 
program for 3D reconstruction and the SolidWorks engineering software. The RMI DICOM files were processed 
using the InVesalius34 software aimed to reconstruct and create STL files. All 3D surface files were created using 
the same threshold parameters (i.e., 0 = dark and 10000 = light, grey level). As SE images exhibit light and dark 
artifacts, two surface files were obtained (thresholds between 0–3000 for dark and 8000–10000 for light artifacts). 
GRE 3D surfaces were obtained using thresholds between 0–3000 for dark grey levels. Afterwards, SolidWorks 
was used to assembly the STL files, to calculate the total volume for both SE and GRE files, and to generate 3D 
PDF interactive files.
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